SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

CAW (crow with knife) is actively trending as a multichain meme coin, driven by its organic, community-led growth across major networks like Solana, Cronos, and Base. The community is highly engaged, frequently discussing its deflationary burn mechanism, strategic partnerships, and increasing accessibility on prominent crypto platforms. This strong collective sentiment fuels its narrative as a rising player within the meme coin sector.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is actively trending as major financial institutions, including the European Central Bank and JP Morgan, increasingly integrate its network for stablecoins and wholesale settlements. Community discussions highlight this growing institutional adoption as a key driver for long-term value, even amidst debates over short-term price volatility and market manipulation. Further advancements in zkEVM technology and significant accumulation by large holders like Bitmine also fuel conversations about Ethereum's foundational role in the evolving digital finance landscape.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as investors navigate a complex energy market, balancing ongoing geopolitical supply disruptions, such as attacks on Russian infrastructure and US sanctions, against concerns of a global oil surplus. Despite recent sideways price action, many in the community are actively accumulating, anticipating a significant breakout driven by long-term demand from the rapid expansion of AI and data centers, complemented by its attractive dividend yield.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is a trending topic amidst news of a strategic partnership with 21Shares US to explore proposed investment products like a CRO Private Trust and ETF, aimed at expanding regulated access to the Cronos ecosystem. Concurrently, there's significant community discussion around the multi-chain meme coin "crow with knife" ($CAW), with many believing it will inject substantial volume into the Cronos chain and benefit CRO. Despite these potential catalysts, sentiment is divided, as a vocal segment of holders expresses frustration over CRO's prolonged price stagnation.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is a hot topic amid ongoing progress in integrating Alani Nu and Rockstar into PepsiCo's distribution, signaling significant future market share gains and international expansion. Community sentiment is largely bullish, viewing recent stock price fluctuations as a 'manipulation' or 'buying opportunity,' believing the brand is deeply undervalued compared to competitors and poised for substantial growth.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is a hot topic, fueled by recent developments such as the launch of quantum-safe state proofs, institutional partnerships with Noah HQ, and robust ecosystem growth from hackathons. This positive outlook clashes with a vocal community segment expressing strong bearish sentiment, citing concerns about the Algorand Foundation's management and anticipating further price declines. The ongoing debate, coupled with activity around the Folks Finance token, underscores a highly speculative environment for ALGO.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing strong community discussion, primarily fueled by a recent institutional downgrade that has intensified debates about its high valuation and perceived underperformance compared to other semiconductor stocks. Despite this, many investors remain bullish, highlighting Arm's foundational role in AI infrastructure, power-efficient architecture, and strategic partnerships as key drivers for significant long-term growth in robotics and autonomous technologies.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amidst community discussions regarding Visa's integration of USDC for settlements on its blockchain, highlighting its role in institutional transactions. While many anticipate future growth driven by its high-performance ecosystem and ongoing meme coin development, others are expressing caution about current price movements and the implications of a new lawsuit.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending due to widespread anticipation of a significant strategic partnership announcement with a major government or military AI entity, which its CEO indicated would be disclosed before year-end. This potential "game-changer" is sparking intense community debate, with many optimistic about its impact on market leadership and growth, while others express skepticism over past delays and the stock's recent volatility within the small-cap AI sector.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending with immense community enthusiasm, actively spreading its 'infection' through pervasive meme culture and consistent cross-promotion, especially with $CAW. The community emphasizes the project's 'sturdy' nature, fun-focused environment, and bullish long-term vision within the Solana and Pump.fun ecosystem, driving continuous discussion and engagement.

statis crypto Watchlist

Bitcoin

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mid Cap Stocks To Watch Today - December 20th

Amicus Therapeutics, ProShares UltraPro Short QQQ, and Solstice Advanced Mat are the three Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap stocks are shares of...

Top Biotech Stocks To Add to Your Watchlist - December 20th

Amicus Therapeutics, Vertex Pharmaceuticals, Danaher, United Therapeutics, Moderna, Cidara Therapeutics, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock...

Assenagon Asset Management S.A. Lowers Stake in Amicus Therapeutics, Inc. $FOLD

Assenagon Asset Management S.A. cut its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 47.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The...

Mid Cap Stocks To Follow Today - December 19th

Amicus Therapeutics, ProShares UltraPro Short QQQ, and Direxion Daily TSLA Bull 2X Shares are the three Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid cap stocks...

Top Value Stocks To Follow Now - December 19th

Invesco QQQ, CoreWeave, Rocket Lab, Amicus Therapeutics, ProShares UltraPro Short QQQ, Rivian Automotive, and Uber Technologies are the seven Value stocks to watch today, according to MarketBeat's...

Top Medical Stocks To Watch Today - December 19th

Eli Lilly and Company, Amicus Therapeutics, UnitedHealth Group, Johnson & Johnson, and AbbVie are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

Promising Biotech Stocks To Follow Now - December 19th

Amicus Therapeutics, Vertex Pharmaceuticals, Danaher, Moderna, United Therapeutics, argenex, and Abivax are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates

VTRS scores four regulatory wins in 2025, from FDA approval of a generic Sandostatin LAR to NDA and IND clearances across its pipeline.

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap Up - Time to Buy?

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap Up - Here's Why...

Needham & Company LLC Reaffirms "Hold" Rating for Amicus Therapeutics (NASDAQ:FOLD)

Needham & Company LLC reissued a "hold" rating on shares of Amicus Therapeutics in a research note on Friday...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FOLD News

FOLDAmicus Therapeutics Inc